New Results
Tumor subclonal progression model for cancer hallmark acquisition
View ORCID ProfileYusuke Matsui, Satoru Miyano, Teppei Shimamura
doi: https://doi.org/10.1101/149252
Yusuke Matsui
1 Nagoya University Graduate School of Medicine, Division of Systems Biology, 65 Tsurumai-cho Showa-ku, Nagoya, 466-8550, Japan,
Satoru Miyano
2 Institute of Medical Science, The University of Tokyo, Laboratory of DNA Information Analysis, Human Genome Center, 4-6-1 Shirokanedai, Minatoku, Tokyo 108-8639, Japan
Teppei Shimamura
1 Nagoya University Graduate School of Medicine, Division of Systems Biology, 65 Tsurumai-cho Showa-ku, Nagoya, 466-8550, Japan,

Article usage
Posted June 12, 2017.
Tumor subclonal progression model for cancer hallmark acquisition
Yusuke Matsui, Satoru Miyano, Teppei Shimamura
bioRxiv 149252; doi: https://doi.org/10.1101/149252
Subject Area
Subject Areas
- Biochemistry
- Biochemistry (14175)
- Bioengineering (10827)
- Bioinformatics (34315)
- Biophysics (17656)
- Cancer Biology (14758)
- Cell Biology (20784)
- Clinical Trials (138)
- Developmental Biology (11183)
- Ecology (16502)
- Epidemiology (2067)
- Evolutionary Biology (20813)
- Genetics (13677)
- Genomics (19100)
- Immunology (14246)
- Microbiology (33158)
- Molecular Biology (13835)
- Neuroscience (72410)
- Paleontology (542)
- Pathology (2278)
- Pharmacology and Toxicology (3860)
- Physiology (6102)
- Plant Biology (12390)
- Synthetic Biology (3461)
- Systems Biology (8371)
- Zoology (1913)